Related Experiment Video
Updated: Nov 4, 2025

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
Published on: May 10, 2021
Identification of key genes in calcific aortic valve disease via weighted gene co-expression network analysis
Jin-Yu Sun1, Yang Hua1, Hui Shen1
1Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210000, China.
Insights
Calcific aortic valve disease (CAVD) mechanisms are unclear. This study identified SPP1, TNC, SCG2, FAM20A, and CD52 as potential hub genes linked to CAVD, offering targets for future therapies.
Area of Science:
- Cardiovascular Biology
- Genomics
- Molecular Biology
Background:
- Calcific aortic valve disease (CAVD) is a prevalent condition in the elderly, leading to aortic valve stenosis.
- The precise molecular mechanisms driving CAVD progression are not fully understood.
Purpose of the Study:
- To identify key genes and molecular pathways involved in the development of CAVD.
- To uncover potential therapeutic targets for CAVD.
Main Methods:
- Analysis of gene expression profiles using 'limma' and weighted gene co-expression network analysis (WGCNA).
- Enrichment analysis (GO, KEGG) and protein-protein interaction network construction.
- Identification of hub genes using mixed character calculation.
Main Results:
- The blue and yellow modules were identified as key modules associated with CAVD.
- Enrichment analysis highlighted leukocyte migration and extracellular matrix components.
- SPP1, TNC, SCG2, FAM20A, and CD52 were identified as significant hub genes.
Conclusions:
- SPP1, TNC, SCG2, FAM20A, and CD52 are proposed as potential hub genes implicated in CAVD.
- These findings provide a basis for further research into CAVD mechanisms and therapeutic strategies.
Background:
Calcific aortic valve disease (CAVD) is the most common subclass of valve heart disease in the elderly population and a primary cause of aortic valve stenosis. However, the underlying mechanisms remain unclear.
Methods:
The gene expression profiles of GSE83453, GSE51472, and GSE12644 were analyzed by 'limma' and 'weighted gene co-expression network analysis (WGCNA)' package in R to identify differentially expressed genes (DEGs) and key modules associated with CAVD, respectively. Then, enrichment analysis was performed based on Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, DisGeNET, and TRRUST database. Protein-protein interaction network was constructed using the overlapped genes of DEGs and key modules, and we identified the top 5 hub genes by mixed character calculation.
Results:
We identified the blue and yellow modules as the key modules. Enrichment analysis showed that leukocyte migration, extracellular matrix, and extracellular matrix structural constituent were significantly enriched. SPP1, TNC, SCG2, FAM20A, and CD52 were identified as hub genes, and their expression levels in calcified or normal aortic valve samples were illustrated, respectively.
Conclusions:
This study suggested that SPP1, TNC, SCG2, FAM20A, and CD52 might be hub genes associated with CAVD. Further studies are required to elucidate the underlying mechanisms and provide potential therapeutic targets.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Regulation of Expression at Multiple Steps

